Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

ClinicalTrials.gov ID: NCT05827068

Public ClinicalTrials.gov record NCT05827068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Randomized, Open-Label Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults 50 to 75 Years of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure the safety and the immune response to 3 next-generation influenza vaccine candidates (mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1) compared with influenza vaccine candidate mRNA-1010 controls in healthy adult participants.

Study identification

NCT ID
NCT05827068
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
ModernaTX, Inc.
Industry
Enrollment
698 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
50 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2023
Primary completion
Nov 19, 2023
Completion
Nov 19, 2023
Last update posted
Feb 2, 2025

2023

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Long Beach Research Institute Lakewood California 90805
Long Beach Clinical Trials Long Beach California 90806
Tekton Research Fort Collins Colorado 80528
Critical Care, Pulmonary and Sleep Associates / CCT Research Lakewood Colorado 80228
CenExel RCA Hollywood Florida 33024
Suncoast Research Associates, LLC Miami Florida 33173
CenExel FCR Tampa Florida 33613
Georgia Clinic / CCT Research Norcross Georgia 30092
CenExel CBH Gaithersburg Maryland 20877
DelRicht Research Rockville Maryland 20852
DelRicht Research Springfield Missouri 65807
Sundance Clinical Research, LLC St Louis Missouri 63141
DelRicht Research Town and Country Missouri 63017
Meridian Clinical Research, LLC Omaha Nebraska 68134
Healor Primary Care Las Vegas Nevada 89102
Meridian Clinical Research, LLC Vestal New York 13850
Tekton Research Edmond Oklahoma 73013
Tekton Research Moore Oklahoma 73160
The Corvallis Clinic, PC Corvallis Oregon 97330
Hatboro Medical Associates / CCT Research Hatboro Pennsylvania 19040
Trial Management Associates, LLC Myrtle Beach South Carolina 29572
Springville Dermatology / CCT Research Springville Utah 84663

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05827068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2025 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05827068 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →